Morepen Laboratories has clarified that the company has recently reported all the announcements to Stock Exchanges as per Regulation 30 of the SEBI (LODR) Regulations, 2015 (as amended). The company has confirmed that there is no pending announcement, event or unpublished price-sensitive information (‘UPSI) that could have impacted the price or volume behaviour of the company's shares. The movement in price in the shares may be market driven.
The above information is a part of company’s filings submitted to BSE.
